A Novel Endoscopic Capsule Sponge Technique Supporting Early Detection and Risk Stratification in Barrett’s Neoplasia
Endoscopy · 01.06.2026 · 58 (S 03 S 03) · S282
DOI: 10.1055/s-0046-1821116 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.06.2026. Verfasst von P Stougie und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Problem to solve Effective surveillance of Barrett’s esophagus (BE) requires representative sampling of the metaplastic epithelium to enable early detection of dysplasia or adenocarcinoma. However, the current gold standard of forceps biopsies is limited by sampling error, interobserver variability in histopathological assessment, and poor integration with emerging molecular diagnostic strategies. Although novel widefield sampling devices have shown promise for more extensive coverage of the BE segment, their clinical adoption is often restricted by patient intolerance or inadequate sampling. As a result, obtaining truly representative tissue samples remains technically challenging. Innovation We use a transendoscopic sampling (TES) technique involving a dissolvable capsule sponge to enable comprehensive sampling during routine endoscopy. The capsule is introduced into the stomach alongside the endoscope using a biopsy forceps. Upon dissolution, it expands into a rough-textured sponge. While the endoscopist inspects and cleans the BE segment, the sponge is deployed and subsequently retrieved transorally, collecting cells from the entire BE without cross-contamination. The procedure results in visible abrasions across the entire BE segment, including targeted suspicious lesions.
Results
In a prospective series of 226 TES procedures, technical success was achieved in 224/226 cases (99.1%). 2/226 procedures failed due to severe esophageal stenosis that prevented passage of the capsule sponge. All 64 BE patients with histologically confirmed progression (high-grade dysplasia or esophageal adenocarcinoma) or endoscopically suspicious lesions underwent successful sampling. In 100% of the successfully retrieved samples (224/224), sufficient material was collected for DNA isolation.
Conclusions
Transendoscopic sampling using the capsule sponge is a safe, well-tolerated, and technically feasible procedure for widefield sampling of BE. It offers a scalable platform for integrating molecular biomarkers into routine surveillance and has the potential to complement, or even revolutionize, endoscopic surveillance in Barrett’s esophagus. Video http://data.process.y-congress.com/ScientificProcess/Data//106/660/1670/e2bec4c5-7d51-4547-b086-238def989bb6/Uploads/19990_1764785095921926.mp4 Publication History Article published online: 05 June 2026 © 2026. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Stougie, P., Wajon, D., Pouw, R., Kramer, G. M., & Duits, L. (2026). A Novel Endoscopic Capsule Sponge Technique Supporting Early Detection and Risk Stratification in Barrett’s Neoplasia. Endoscopy, 58(S 03 S 03), S282. https://doi.org/10.1055/s-0046-1821116
Vancouver
Stougie P, Wajon D, Pouw R, Kramer GM, Duits L. A Novel Endoscopic Capsule Sponge Technique Supporting Early Detection and Risk Stratification in Barrett’s Neoplasia. Endoscopy. 2026;58(S 03 S 03):S282. doi:10.1055/s-0046-1821116
BibTeX
@article{Stougie2026,
author = {Stougie, P and Wajon, D and Pouw, R and Kramer, G M and Duits, L},
title = {A Novel Endoscopic Capsule Sponge Technique Supporting Early Detection and Risk Stratification in Barrett’s Neoplasia},
journal = {Endoscopy},
year = {2026},
volume = {58},
number = {S 03 S 03},
pages = {S282},
doi = {10.1055/s-0046-1821116}
}
EUVIMED